Nashed , MinaWaye, ShannonHasan, SM NageebNguyen, DianaWiseman, MicaelaZhang, JingLau, HarryDinesh, O. ChandaniRaymond, RogerGreig, IainRodriguez Bambico, FrancisNobrega, Jose2023-01-042023-01-042022-01Nashed , M, Waye, S, Hasan, SM N, Nguyen, D, Wiseman, M, Zhang, J, Lau, H, Dinesh, O C, Raymond, R, Greig, I, Rodriguez Bambico, F & Nobrega, J 2022, 'Antidepressant Activity of Pharmacological and Genetic Deactivation of the Small-Conductance Calcium-Activated Potassium Channel Subtype-3', Psychopharmacology, vol. 239, no. 1, pp. 253-266. https://doi.org/10.1007/s00213-021-06045-w0033-3158ORCID: /0000-0003-0603-3383/work/109934886https://hdl.handle.net/2164/19788Funding and Disclosure This research was supported by awards from the Neuroscience Catalyst program (Toronto) (FRB and JNN), the Canadian Institutes of Health Research (FRB and JN) and the National Science and Engineering Research Council of Canada (FRB). M.N. was additionally supported by a CAMH Discovery Fund Post-doctoral Fellowship. Conflict of Interest: None declared. Acknowledgments We thank J. Li, U. Mumtaz, S. Khan, S. Sivaruban, M. Billyard, E. Hauck, D. Oleinichenko, Michael Coombs and Lucas Francis Fowler for technical assistance at different stages of the work.141303976engsmall-conductance calcium-activated potassium (SK) channelantidepressantchronic unpredictable mild stressprefrontal cortexSK3 NAMR MedicineRAntidepressant Activity of Pharmacological and Genetic Deactivation of the Small-Conductance Calcium-Activated Potassium Channel Subtype-3Journal article10.1007/s00213-021-06045-whttp://www.scopus.com/inward/record.url?scp=85122312599&partnerID=8YFLogxK2391